Evolving Use of Real-World Evidence for Devices: Good for Patients, Good for Policy Makers

被引：3
|
作者：
Mullins, C. Daniel [1 ]
机构：
[1] Univ Maryland, Sch Pharm, Dept Pharmaceut Hlth Serv Res, Baltimore, MD 21201 USA
来源：
VALUE IN HEALTH | 2019年 / 22卷 / 07期
关键词：
TASK-FORCE;
D O I：
10.1016/j.jval.2019.04.1923
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：751 / 753
页数：3
相关论文
共 50 条
  • [1] Real-World Use of Inhaled COPD Medications: the Good, the Bad, the Ugly
    Press, Valerie G.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2024, 11 (04): : 331 - 340
  • [2] Is Good Enough for Our Peers Good Enough for Policy Makers?
    Luft, Harold S.
    HEALTH SERVICES RESEARCH, 2018, 53 (01) : 9 - 14
  • [3] Interventions to Do Real-World Good: Generalization and Persistence
    Green, C. Shawn
    PSYCHOLOGICAL SCIENCE IN THE PUBLIC INTEREST, 2020, 21 (02) : 43 - 49
  • [4] Real-World Data on Reperfusion: Evidence of Good Outcomes in the International Trevo Retriever Registry
    Liebeskind, David S.
    Woolf, Graham W.
    Xiang, Bin
    Shields, Ryan
    Veznedaroglu, Erol
    English, Joey
    Baxter, Blaise W.
    Budzik, Ronald F.
    Bartolini, Bruno M.
    Krajina, Antonin
    Sarraj, Amrou
    Narata, A.
    Miller, T.
    Grobelny, T.
    Nogueira, R. G.
    Gupta, R.
    Jadhav, A.
    STROKE, 2017, 48
  • [5] Antitrust Enforcement: A Good Bargain for Policy Makers
    Lasserre, Bruno
    JOURNAL OF EUROPEAN COMPETITION LAW & PRACTICE, 2011, 2 (05) : 421 - 422
  • [6] TYPE 2 DIABETES MELLITUS: LACK OF GOOD PRACTICES FOR REAL-WORLD EVIDENCE STUDIES.
    Lambert-Obry, V
    Lafrance, J.
    Savoie, M.
    Lachaine, J.
    VALUE IN HEALTH, 2018, 21 : S389 - S389
  • [7] Review of real-world evidence studies in type 2 diabetes mellitus: Lack of good practices
    Lambert-Obry, Veronique
    Lafrance, Jean-Philippe
    Savoie, Michelle
    Henri, Sandrine
    Lachaine, Jean
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2020, 36 (04) : 372 - 379
  • [8] In the Real-World, Kids Use Medications and Devices
    Tamar Lasky
    Drugs - Real World Outcomes, 2017, 4 (2) : 75 - 78
  • [9] THE USE OF REAL-WORLD EVIDENCE IN HTA OF CLASS III MEDICAL DEVICES IN EUROPE
    Klein, P.
    de Groot, S.
    Blommestein, H. M.
    Pongiglione, B.
    Torbica, A.
    Al, M. J.
    VALUE IN HEALTH, 2020, 23 : S758 - S758
  • [10] Based on the Real-World Results From Australia, Immunotherapy Is Not a Good Option for Patients With Mesothelioma
    Gray, Steven G.
    Meirson, Tomer
    Mutti, Luciano
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (04) : 541 - 546
12345